A fair growth of 5.27% in the revenue at Rs. 9533.80 millions was reported in the September 2023 quarter as compared to Rs. 9056.10 millions during year-ago period.A slim rise of 11.36% was recorded in the Net profit for the quarter ended September 2023 to Rs. 2155.40  millions  From Rs. 1935.60 millions.Operating profit for the quarter ended September 2023 rose to 3150.50 millions as compared to 2790.80 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 9533.80 9056.10 5.27 16914.00 16350.70 3.45 32163.40 32175.10 -0.04
Other Income 284.70 221.60 28.47 652.70 499.50 30.67 1015.20 762.20 33.19
PBIDT 3150.50 2790.80 12.89 4931.00 4548.00 8.42 9009.30 8320.50 8.28
Interest 4.30 3.90 10.26 7.10 10.70 -33.64 18.10 19.90 -9.05
PBDT 3146.20 2786.90 12.89 5096.90 4537.30 12.33 8981.50 8416.40 6.71
Depreciation 181.10 163.60 10.70 344.70 321.80 7.12 657.70 681.90 -3.55
PBT 2965.10 2623.30 13.03 4752.20 4215.50 12.73 8323.80 7734.50 7.62
TAX 809.70 687.70 17.74 1291.00 1123.60 14.90 2276.80 3968.70 -42.63
Deferred Tax -96.30 -46.30 107.99 -141.30 -81.00 74.44 -183.70 -105.00 74.95
PAT 2155.40 1935.60 11.36 3461.20 3091.90 11.94 6047.00 3765.80 60.58
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 33.05 30.82 7.23 29.15 27.82 4.81 28.01 25.86 8.32

Glaxosmithkline Phar Share Price

2132.75 67.35 (3.26%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.